NYGC ALS Consortium - New York Genome Center

NYGC Scientists Awarded Dept. of Defense Grant to Advance Understanding of Gene Expression in ALS-Frontotemporal Dementia Clinical Spectrum

NEW YORK, NY (December 23, 2021) — Scientists at the New York Genome Center (NYGC) have received an Amyotrophic Lateral Sclerosis Research Program Clinical Development Award from the Department of Defense’s Congressionally Directed Medical Research Programs to lead a project focused on performing single nucleus RNA sequencing of postmortem tissues from patients in the ALS-frontotemporal dementia […]

Molecular Classification and Interpretation of Amyotrophic Lateral Sclerosis Using Deep Convolution Neural Networks and Shapley Values.

2021 NYGC ALS Consortium Meeting: Celebrating Achievements, Ongoing Collaborations to Advance ALS Research

NEW YORK, NY (September 17, 2021) — “We have exceeded our wildest expectations, and that is thanks to all of you.” This expression of appreciation from Hemali Phatnani, PhD, Director, Center for Genomics of Neurodegenerative Disease (CGND) at the New York Genome Center (NYGC), kicked off the third (and first virtual) biannual meeting of the […]

Faculty Labs

NYGC Labs

Blog Archives

NYGC Scientists Awarded Dept. of Defense Grant to Advance Understanding of Gene Expression in ALS-Frontotemporal Dementia Clinical Spectrum

Molecular Classification and Interpretation of Amyotrophic Lateral Sclerosis Using Deep Convolution Neural Networks and Shapley Values.

2021 NYGC ALS Consortium Meeting: Celebrating Achievements, Ongoing Collaborations to Advance ALS Research

Integrative genetic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes.

Common ALS/FTD risk variants in UNC13A exacerbate its cryptic splicing and loss upon TDP-43 mislocalization

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.